CRBP Corbus Pharmaceuticals Holdings, Inc. PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Corbus Pharmaceuticals (CRBP) Stock: Buy, Sell, or Hold?

$3.39
-0.02 (-0.59%) ▼
5d: +10.42% 30d: -21.71% 90d: -67.68%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$3.54 – $4.83
Position: OVERSOLD
Forward P/E & Valuation
-0.6x
Next 12M consensus est.
Wall Street Target
$33.22
+880.0% upside
Options IV & Volume
66th pct IV
HIGH volume confirmation
Support / Resistance
$2.81 / $4.23
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CRBP shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When CRBP Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CRBP is currently trading at $3.39, which is considered oversold relative to its 30-day fair value range of $3.54 to $4.83.

Technical Outlook: Technically, CRBP is in a strong downtrend. Immediate support is located at $2.81, while resistance sits at $4.23.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $33.22 (+880.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $3.54 - $4.83
Company Quality Score 41/100 (HOLD)
Options IV Signal 66th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 80.0%

Trading Range & Key Levels

30-Day Trading Range $3.54 - $4.83
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$0.68 (20.1%)
Support Level $2.81
Resistance Level $4.23
Current Trend Strong Downtrend
Technical data as of Nov 13, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls BREAKDOWN
Days in Phase: 57d (52% conf)
30D Insider Cluster Signal TRACKED
30D Insider Buyers: 0 insiders ($0)
30D Net Insider Flow: $-1,742,755

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Options fairly priced (IV 66th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 880.0% below Wall St target ($33.22)
  • WARNING: Composite score 40/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.64
Wall Street Target $33.22 (+880.0%)
Revenue Growth (YoY) -100.0%
Share CRBP Analysis

Share this live CRBP analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CRBP)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary: Corbus Pharmaceuticals reported a wider-than-expected loss in Q3 2026, with a loss per share of $1.81 versus the expected $1.45.
Key Retail Themes: earnings report financial performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 8:49 PM ET
Data refreshes hourly during market hours. Next update: 9:49 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CRBP.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 49 HOLD
ARGX
argenx NV ADR
STRONG BUY
24 analysts
$1147 33 SELL
DNTH
Dianthus Therapeutics In…
STRONG BUY
18 analysts
$139 35 SELL
ARDX
Ardelyx Inc
STRONG BUY
11 analysts
$13 69 BUY
MRUS
Merus BV
STRONG BUY
17 analysts
$97 39 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive CRBP Research Pages
CRBP Technical Chart CRBP Price Prediction CRBP Intrinsic Value DCF CRBP Earnings Date CRBP Investment Advisor CRBP Fair Price Analyzer CRBP Target Price Playground CRBP LEAP Simulator CRBP Supply Chain Tear-Down CRBP Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals